Showing results (21-30 of 492) with videos related to
Sort By:
Pageof 50
Cancer Gene Therapy|April 18, 2002
TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cellsChristian Beltinger, Simone Fulda, Henning Walczak, et al.Nature Medicine|July 16, 2002
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivoSimone Fulda, Wolfgang Wick, Michael Weller, et al.Anti-Cancer Drugs|November 1, 2012
Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosisStefanie Enzenmüller, Patrick Gonzalez, Klaus-Michael Debatin, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2008
Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappaB-mediated apoptosis resistance and tumor growth in vivoHubert Kasperczyk, Bernd Baumann, Klaus-Michael Debatin, et al.International Journal of Cancer|August 14, 2009
Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosisSandra Loeder, Annekathrin Drensek, Irmela Jeremias, et al.Cancer Research|January 20, 2007
Activation of Akt predicts poor outcome in neuroblastomaDaniela Opel, Christopher Poremba, Thorsten Simon, et al.Anti-Cancer Drugs|May 14, 2011
Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275Annette Bangert, Sabine Häcker, Silvia Cristofanon, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 26, 2010
Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosisIsabelle Mader, Martin Wabitsch, Klaus-Michael Debatin, et al.International Journal of Cancer|December 10, 2008
Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibitionJohannes U Ammann, Christian Haag, Hubert Kasperczyk, et al.Cancer Letters|September 25, 2012
GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell deathStefanie Enzenmüller, Patrick Gonzalez, Georg Karpel-Massler, et al.Pageof 50